CNS drugs

CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes: - Overviews of contentious or emerging issues. - Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses. - Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry. - Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in CNS Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

CNS drugs 是一本专注于推动临床精神病学和神经病学领域内合理药物治疗的学术期刊。该期刊涵盖了一系列内容，包括对有争议或新出现问题的概述、为神经和精神疾病药物治疗提供权威信息的综合叙述性综述、遵循PRISMA声明的系统性综述、介绍新药和老药特性及其治疗地位的Adis药物综述，以及与临床实践紧密相关的原创研究文章，如临床药效学、药代动力学研究、临床试验、荟萃分析、结果研究和药物经济学与药物流行病学研究。此外，期刊还提供多种数字功能，如动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图、播客和动画，旨在增强内容的可见性、扩大读者群并提升教育价值。为了帮助非专业读者理解重要医学进展，发表的文章还可能附有用通俗易懂语言编写的摘要。